Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cognition Disorders

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cognition Disorders in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Medeiros, R1
Figueiredo, CP1
Pandolfo, P1
Duarte, FS1
Prediger, RD1
Passos, GF1
Calixto, JB1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cognition Disorders

ArticleYear
The role of TNF-alpha signaling pathway on COX-2 upregulation and cognitive decline induced by beta-amyloid peptide.
    Behavioural brain research, 2010, May-01, Volume: 209, Issue:1

    Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Antibodies; Cognition Disorders; CREB-Binding

2010